4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-008499
EVP and General Counsel sold 7,373 shares at $9.14 ($67,402)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP and General Counsel | 2025-02-26 | Sale 10b5-1 | −7,373 | $9.14 | $67,402 | 79,460 | D |
| Open-market sales · 7,373 sh · avg $9.14 · $67,402 | |||||||
Loading xslF345X05/wk-form4_1740677961.xml…